Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

Authors: Jürg Bernhard, Weixiu Luo, Karin Ribi, Marco Colleoni, Harold J. Burstein, Carlo Tondini, Graziella Pinotti, Simon Spazzapan, Thomas Ruhstaller, Fabio Puglisi, Lorenzo Pavesi, Vani Parmar, Meredith M. Regan, Olivia Pagani, Gini F. Fleming, Prudence A. Francis, Karen N. Price, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Barbara Walley - The Lancet 2015 cited by 179